Investor alert: pomerantz law firm investigates claims on behalf of investors of sarepta therapeutics, inc. - srpt

New york, may 09, 2025 (globe newswire) -- pomerantz llp is investigating claims on behalf of investors of sarepta therapeutics, inc. (“sarepta” or the “company”) (nasdaq: srpt). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

SRPT Ratings Summary

SRPT Quant Ranking